Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus

Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus

Summary: Epstein-Barr virus (EBV) is a cancer-associated pathogen for which there is no vaccine. Successful anti-viral vaccines elicit antibodies that neutralize infectivity; however, it is unknown whether neutralizing antibodies prevent EBV acquisition. Here we assessed whether passively delivered...

Full description

Bibliographic Details
Main Authors:	Swati Singh, Leah J. Homad, Nicholas R. Akins, Claire M. Stoffers, Stefan Lackhar, Harman Malhi, Yu-Hsin Wan, David J. Rawlings, Andrew T. McGuire
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	Cell Reports Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666379120300458

Similar Items

Epidemiological surveillance of lymphocryptovirus infection in wild bonobos
by: Tomoyuki Yoshida, et al.
Published: (2016-08-01)

Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants
by: Tierra Smiley Evans, et al.
Published: (2017-07-01)

The first endogenous herpesvirus, identified in the tarsier genome, and novel sequences from primate rhadinoviruses and lymphocryptoviruses.
by: Amr Aswad, et al.
Published: (2014-06-01)

Induction of encephalitis in rhesus monkeys infused with lymphocryptovirus-infected B-cells presenting MOG(34-56) peptide.
by: Krista G Haanstra, et al.
Published: (2013-01-01)

Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects
by: Madeleine F. Jennewein, et al.
Published: (2021-07-01)

Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.
by: Junji Sashihara, et al.
Published: (2011-10-01)

Lymphocryptovirus-dependent occurrence of lymphoma in SIV-infected rhesus macaques with particular consideration to two uncommon cases of non-Hodgkin's lymphoma
by: A. Klippert, et al.
Published: (2016-12-01)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
by: Nicholas K. Hurlburt, et al.
Published: (2020-10-01)

Two sides to the same antibody: assessing the role of neutralizing and non-neutralizing antibodies in mother-to-child transmission of HIV-1
by: Ghulam-Smith, Melissa
Published: (2019)

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
by: Jérémy Dufloo, et al.
Published: (2018-07-01)

HIV-1 autologous antibody neutralization associates with mother to child transmission.
by: Elly Baan, et al.
Published: (2013-01-01)

Sub-domains of ricin's B subunit as targets of toxin neutralizing and non-neutralizing monoclonal antibodies.
by: Anastasiya Yermakova, et al.
Published: (2012-01-01)

Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
by: Emilie Seydoux, et al.
Published: (2021-05-01)

Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
by: Shilei Ding, et al.
Published: (2020-10-01)

Neutralizing antibodies for orthobunyaviruses in Pantanal, Brazil.
by: Alex Pauvolid-Corrêa, et al.
Published: (2017-11-01)

Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
by: Katie A. Howell, et al.
Published: (2017-04-01)

Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.
by: Oliver F Brandenberg, et al.
Published: (2017-05-01)

Skirmishes : With Friends, Enemies, and Neutrals
by: Harman, Graham
Published: (2020)

New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
by: Kathleen A. McGuire, et al.
Published: (2017-06-01)

A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes
by: Camila H. Coelho, et al.
Published: (2021-03-01)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
by: Laura E McCoy, et al.
Published: (2015-08-01)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
by: Celia C LaBranche, et al.
Published: (2018-11-01)

Passive immunoprophylaxis against primate immunodeficiency virus transmission using human neutralizing monoclonal antibodies
by: VLASÁK, Josef
Published: (2007)

Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity
by: Melissa Ghulam-Smith, et al.
Published: (2017-10-01)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
by: Celia C LaBranche, et al.
Published: (2019-03-01)

The breadth of maternal HIV-1 specific neutralizing antibodies is not associated with a lower risk of mother-to-infant transmission
by: Chaillon A, et al.
Published: (2012-09-01)

Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
by: K. Rachael Parks, et al.
Published: (2019-12-01)

A Comparative Analysis of the Revised Children's Manifest Anxiety Scale Scores of Traumatized Youth With and Without PTSD Relative to Non-Traumatized Controls
by: McGuire, Leah Anne
Published: (2013)

Potential role for neutralizing antibodies in HIV-1 infection
by: J. Mascola
Published: (2015-12-01)

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
by: Andrabi, R., et al.
Published: (2022)

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus.
by: Anna Bootz, et al.
Published: (2017-08-01)

Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.
by: Chia Yin Lee, et al.
Published: (2011-12-01)

Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent.
by: Lucia Reh, et al.
Published: (2015-07-01)

Broad dengue neutralization in mosquitoes expressing an engineered antibody.
by: Anna Buchman, et al.
Published: (2020-01-01)

An investigation into the utility of the Mini Addenbrooke's Cognitive Examination (M-ACE) for the early detection of dementia and mild cognitive impairment in people aged 75 and over
by: McGuire, Claire
Published: (2016)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
by: Elise Landais, et al.
Published: (2018-09-01)

Neutralizing Antibody Response and SARS Severity
by: Mei-Shang Ho, et al.
Published: (2005-11-01)

The interaction of influenza virus with neutralizing antibody
by: Taylor, Howard Paul
Published: (1986)

Neutralizing Antibody Therapeutics for COVID-19
by: Aeron C. Hurt, et al.
Published: (2021-04-01)

Differences in Allelic Frequency and CDRH3 Region Limit the Engagement of HIV Env Immunogens by Putative VRC01 Neutralizing Antibody Precursors
by: Christina Yacoob, et al.
Published: (2016-11-01)